Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | THRB | P10828 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.32 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4889687 | 0.98 | TSHR (0.47) | TSHRALDH1A1THRBATMHCAR2 | |
| SCHEMBL4888147 | 0.89 | ATM (0.48) | TSHRALDH1A1THRBATMHCAR2 | |
| SCHEMBL6466648 | 0.89 | HCAR2 (0.54) | TSHRALDH1A1ATMHCAR2MAPT | |
| SCHEMBL3791086 | 0.88 | TSHR (0.50) | TSHRALDH1A1THRBATMHCAR2 | |
| SCHEMBL3786038 | 0.88 | TSHR (0.50) | TSHRALDH1A1THRBATMHCAR2 | |
| SCHEMBL4888226 | 0.87 | HCAR2 (0.47) | TSHRALDH1A1THRBATMHCAR2 | |
| SCHEMBL4888287 | 0.87 | HCAR2 (0.47) | TSHRALDH1A1THRBATMHCAR2 | |
| SCHEMBL35576 | 0.84 | ATM (0.56) | TSHRALDH1A1THRBATMHCAR2 | |
| SCHEMBL4889702 | 0.84 | ATM (0.56) | TSHRALDH1A1THRBATMHCAR2 | |
| SCHEMBL2897724 | 0.84 | ALDH1A1 (0.60) | TSHRALDH1A1THRBATMHCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 526 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4717744-A1 | USE OF A COMPOSITION BASED ON CYANOACRYLATE AND (METH)ACRYLATE | Bostik SA (FR) | 2026-04-01 | — | — | EP | claimed |
| US-20260041183-A1 | ADHESIVE FOR COSMETIC ARTICLE AND METHOD OF FORMING | FULLER H B CO (US) | 2026-02-12 | — | — | US | claimed |
| US-20250215132-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2025-07-03 | — | — | US | claimed |
| WO-2025119862-A1 | COMPOSITION COMPRISING N-HEPTYLCYANOACRYLATE | BOSTIK SA (FR) | 2025-06-12 | — | — | WO | claimed |
| EP-4567084-A1 | COMPOSITION COMPRISING N-HEPTYLCYANOACRYLATE | Bostik SA (FR) | 2025-06-11 | — | — | EP | claimed |
| CN-116209729-B | Thickener for cyanoacrylate-based adhesives | 旭化成株式会社 | 2025-04-08 | — | — | CN | claimed |
| EP-4504844-A1 | TWO-PART CURABLE COMPOSITION | Bostik SA (FR) | 2025-02-12 | — | — | EP | claimed |
| US-12157784-B2 | Two-part curable composition | BOSTIK SA (FR) | 2024-12-03 | — | — | US | claimed |
| CN-114621398-B | Stretchable cyanoacrylate tissue adhesives and uses thereof | 香港科技大学 | 2024-04-30 | — | — | CN | claimed |
| CN-111615666-B | Method for producing planar polymer stacks | 阿科玛法国公司 | 2024-02-06 | — | — | CN | claimed |
| WO-2007026196-A2 | QUALITY CONTROLLED ARTIFICIAL EYELASHES EXTENSION SYSTEM | NOVALASH INC. (US) | 2007-03-08 | — | — | WO | claimed |
| US-20070050207-A1 | QUALITY CONTROLLED ARTIFICIAL EYELASHES EXTENSION SYSTEM | NOVALASH INC. | 2007-03-01 | — | — | US | claimed |
| US-6605667-B1 | 1,1-disubstituted ethylene monomers such as alpha-cyano-acrylates; storage stability | CLOSURE MEDICAL CORPORATION | 2003-08-12 | — | — | US | claimed |
| US-20030149128-A1 | Stabilized monomer adhesive compositions | CLOSURE MEDICAL CORPORATION | 2003-08-07 | — | — | US | claimed |
| EP-0965623-B1 | Stabilized monomer adhesive compositions | CLOSURE MEDICAL CORP (US) | 2003-05-02 | — | — | EP | claimed |
| US-20030082116-A1 | Adhesive compositions containing dual function stabilizers and active agents | CLOSURE MEDICAL CORPORATION (US) | 2003-05-01 | — | — | US | claimed |
| US-6512023-B1 | An adhesive composition includes a polymerizable adhesive monomer, at least one vapor phase stabilizer, and at least one liquid phase stabilizer. The combination of at least one vapor phase stabilizer and at least one liquid phase | CLOSURE MEDICAL CORPORATION | 2003-01-28 | — | — | US | claimed |
| US-20020055573-A1 | Stabilized monomer adhesive compositions | CLOSURE MEDICAL CORPORATION (US) | 2002-05-09 | — | — | US | claimed |
| WO-2002020069-A2 | ANTIOXIDANT ENRICHED ADHESIVE COMPOSITIONS AND STORAGE CONTAINERS THEREFOR | CLOSURE MEDICAL CORPORATION (US) | 2002-03-14 | — | — | WO | claimed |
| EP-0965623-A1 | Stabilized monomer adhesive compositions | Closure Medical Corporation (US) | 1999-12-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260041183-A1 | ADHESIVE FOR COSMETIC ARTICLE AND METHOD OF FORMING | KRT18, CDH1, CFL1 | TSHR 3226/4885ALDH1A1 556/4885THRB 1859/4885 |
| US-20030082116-A1 | Adhesive compositions containing dual function stabilizers and active agents | TLN1, PTK2, ILK | TSHR 4697/4885ALDH1A1 812/4885THRB 4101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.